Share:
Non-Malaysian citizens are subject to 6% SST, to be verified and paid at the counter before screening.
CA72-4 (CA724) Test — Gastric Cancer Tumor Marker
Introduction
CA72-4 (also written as CA724) is a carbohydrate antigen used as a supportive tumor marker for gastric cancer and some gastrointestinal malignancies. It assists in risk assessment, treatment monitoring, and recurrence follow-up. Note that an elevated value alone does not equal a diagnosis; results must be interpreted with imaging and clinical findings.
Why Take a CA72-4 Test?
- Supportive evaluation: Helps assess risk when gastric or GI cancers are suspected.
- Treatment monitoring: Track levels before/after therapy to gauge response.
- Recurrence surveillance: Long-term follow-up in line with clinical plans.
Method & Workflow
A venous blood sample is collected to measure serum CA72-4. Results are typically available within 2–3 working days (lab-dependent).
Interpretation should be combined with clinical presentation, endoscopy/imaging, and other markers (e.g., CEA, CA19-9).
Factors & Notes
- Mild elevations may be seen in benign conditions (e.g., inflammation).
- Reference ranges vary by laboratory and method; follow your report’s range.
- Clinical decisions are based on trends over time and combined assessments.
Who Should Consider Testing?
- Patients with suspected GI malignancy as advised by physicians
- Confirmed gastric cancer patients requiring response/recurrence monitoring
- Individuals included in a tumor marker panel per clinical judgment
Frequently Asked Questions (FAQ)
Q1: Does a high CA72-4 always mean gastric cancer?
A: No. Benign diseases can also increase CA72-4. Diagnosis requires endoscopy, imaging, and pathology.
Q2: Is CA72-4 suitable for general population screening?
A: Not as a stand-alone test. It is best used alongside clinical evaluation, imaging, and other markers.
Q3: How should I interpret the report?
A: Focus on serial trends rather than a single value, and consult your doctor with all finding
Inquiry - Gastrointestinal Cancer CA724
